Lirum Therapeutics Presents Data on LX-101, a Novel Clinical-Stage Targeted Therapy,…
NEW YORK, June 05, 2023 (GLOBE NEWSWIRE) -- Lirum Therapeutics, Inc. (“Lirum”), an innovative clinical-stage biopharmaceutical company focused on the treatment of debilitating diseases,…